Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrina R Swett

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The American Surgeon|January 9, 2015
Total body surface area overestimation at referring institutions in children transferred to a burn centerDouglas S Swords, Edmund D Hadley, Katrina R Swett, et al.
Annals of Plastic Surgery|May 16, 2013
The plastic surgery match: predicting success and improving the processJeffrey R Claiborne, J Clayton Crantford, Katrina R Swett, et al.
The American Surgeon|May 29, 2013
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosisReese W Randle, Katrina R Swett, Perry Shen, et al.
Traffic Injury Prevention|June 2, 2015
Estimated injury risk for specific injuries and body regions in frontal motor vehicle crashesAshley A Weaver, Jennifer W Talton, Ryan T Barnard, et al.
Annals of Surgical Oncology|July 19, 2014
Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Shuja Ahmed, Edward A Levine, Reese W Randle, et al.
Annals of Surgical Oncology|August 29, 2013
Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascitesReese W Randle, Katrina R Swett, Douglas S Swords, et al.
Annals of Surgical Oncology|June 27, 2013
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumorsKonstantinos I Votanopoulos, Douglas S Swords, Katrina R Swett, et al.
Journal of Surgical Oncology|September 28, 2018
Analysis of recurrence after the resection of pancreatic neuroendocrine tumorsKonstantinos Chouliaras, Naeem A Newman, Mrinal Shukla, et al.
Annals of Surgical Oncology|November 13, 2013
Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Konstantinos I Votanopoulos, Reese W Randle, Brandon Craven, et al.
Journal of Surgical Oncology|January 6, 2015
Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapyReese W Randle, Shuja Ahmed, Edward A Levine, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The American Surgeon|January 9, 2015
Total body surface area overestimation at referring institutions in children transferred to a burn centerDouglas S Swords, Edmund D Hadley, Katrina R Swett, et al.
Annals of Plastic Surgery|May 16, 2013
The plastic surgery match: predicting success and improving the processJeffrey R Claiborne, J Clayton Crantford, Katrina R Swett, et al.
The American Surgeon|May 29, 2013
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosisReese W Randle, Katrina R Swett, Perry Shen, et al.
Traffic Injury Prevention|June 2, 2015
Estimated injury risk for specific injuries and body regions in frontal motor vehicle crashesAshley A Weaver, Jennifer W Talton, Ryan T Barnard, et al.
Annals of Surgical Oncology|July 19, 2014
Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Shuja Ahmed, Edward A Levine, Reese W Randle, et al.
Annals of Surgical Oncology|August 29, 2013
Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascitesReese W Randle, Katrina R Swett, Douglas S Swords, et al.
Annals of Surgical Oncology|June 27, 2013
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumorsKonstantinos I Votanopoulos, Douglas S Swords, Katrina R Swett, et al.
Journal of Surgical Oncology|September 28, 2018
Analysis of recurrence after the resection of pancreatic neuroendocrine tumorsKonstantinos Chouliaras, Naeem A Newman, Mrinal Shukla, et al.
Annals of Surgical Oncology|November 13, 2013
Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Konstantinos I Votanopoulos, Reese W Randle, Brandon Craven, et al.
Journal of Surgical Oncology|January 6, 2015
Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapyReese W Randle, Shuja Ahmed, Edward A Levine, et al.
Pageof 2